Inmed pharmaceuticals to present at the h.c. wainwright 23rd annual global investment conference

Vancouver, british columbia, sept. 09, 2021 (globe newswire) -- inmed pharmaceuticals inc. (“inmed” or the “company”) (nasdaq: inm), a leader in the manufacturing and clinical development of rare cannabinoids, today announced that eric. a. adams, president and ceo of inmed will present at the h.c. wainwright 23rd annual global investment conference which is being held virtually from september 13-15, 2021.
INM Ratings Summary
INM Quant Ranking